Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Transcripts
  • inderesTV
  • Forum
  • About Us
    • Our Coverage
    • Team

Essity

282.10 SEK

-0.07 %

1,837 following

ESSITY B

NASDAQ Stockholm

Personal Goods

Consumer Goods & Services

Overview
Financials & Estimates
Ownership
Investor consensus
Compare
-0.07 %
+3.71 %
+6.37 %
+9.68 %
+11.90 %
-0.53 %
+0.75 %
+8.08 %
+13.52 %

Essity operates in the hygiene and health industry and focuses on the development, manufacturing and distribution of products within personal care, incontinence and medical care. The company's products are aimed at private individuals and healthcare institutions. The operations are global with a main presence in Europe, North America and Asia. Essity was founded in 2017 and is headquartered in Stockholm, Sweden.

Read more
Market cap
195.51B SEK
Turnover
431.92M SEK
Revenue
-
EBIT %
-
P/E
20.74
Dividend yield-%
-
Revenue and EBIT-%

Revenue B

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
26.3
2026

General meeting '26

27.3
2026

Annual dividend

23.4
2026

Interim report Q1'26

All
Webcasts
Press releases
ShowingAll content types
Press release2/17/2026, 7:00 AM

Invitation to Essity's Capital Markets Day on May 7, 2026

Essity
Regulatory press release2/16/2026, 8:39 AM

Buyback of Class B shares in Essity during week 7, 2026

Essity
Regulatory press release2/9/2026, 9:28 AM

Buyback of Class B shares in Essity during week 6, 2026

Essity

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Press release2/2/2026, 5:19 PM

Essity completes the acquisition of Edgewell's feminine care business

Essity
Regulatory press release2/2/2026, 9:05 AM

Buyback of Class B shares in Essity during week 5, 2026

Essity
Regulatory press release1/30/2026, 7:00 AM

Essity: Conversion of shares

Essity
Press release1/29/2026, 7:00 AM

Essity signs EUR 400m loan agreement with the European Investment Bank

Essity
Regulatory press release1/26/2026, 8:09 AM

Buyback of Class B shares in Essity during week 4, 2026

Essity
Press release1/22/2026, 6:30 AM

Essity recognized on CDP's prestigious lists for forest and climate

Essity
Regulatory press release1/22/2026, 6:00 AM

Essity: Report for quarter 4 and full-year 2025

Essity
Press release1/22/2026, 5:55 AM

Save the date - Essity's Capital Markets Day, May 7, 2026

Essity
Regulatory press release1/19/2026, 8:07 AM

Buyback of Class B shares in Essity during week 3, 2026

Essity
Regulatory press release1/12/2026, 8:29 AM

Buyback of Class B shares in Essity during week 2, 2026

Essity
Regulatory press release1/8/2026, 12:45 PM

Discontinued lawsuit against Essity regarding bond loans

Essity
Regulatory press release1/5/2026, 8:19 AM

Buyback of Class B shares in Essity during week 1, 2026

Essity
Regulatory press release12/30/2025, 7:00 AM

Essity: Conversion of shares

Essity
Regulatory press release12/29/2025, 7:30 AM

Buyback of Class B shares in Essity during week 52, 2025

Essity
Regulatory press release12/22/2025, 8:52 AM

Buyback of Class B shares in Essity during week 51, 2025

Essity
Press release12/17/2025, 7:00 AM

Invitation to presentation of Essity's report for quarter 4 and full year 2025

Essity
Regulatory press release12/15/2025, 9:46 AM

Buyback of Class B shares in Essity during week 50, 2025

Essity
Forum discussions
Let’s continue the almost dead discussion about a quality company. Essity has continued its steady progress. The dividend is growing again and the balance sheet keeps improving. The company is starting to have the strength to either buy back more of its own shares or embark on complementar...
2/14/2025, 12:25 PM
by WidemoatInvesting
7
Essity has very high-quality businesses. The company went public at a valuation that was a bit too high, but the valuation has now settled at reasonable levels. If growth continues, the company’s value should catch up at some point. I would consider it a company with a similar growth...
2/21/2024, 10:51 AM
by WidemoatInvesting
6
Much has happened since the last post. Over the past three years, Essity has diversified by making numerous acquisitions: 2021 -Full acquisition of ABIGO Medical and Asaleo Care (previously partial ownership). -Ownership stake in Productos Familia S.A. was increased to 95.8%. -Acquired...
2/21/2024, 9:16 AM
by Raha-aasi
6
Essity will have a couple of rough quartals ahead of them. That is given, due to lockdowns and costs concerns driven by mass price increases. But that said, Essity is doing everything right, and if I want to be in this space I prefer Essity over KMB, which is heavily in debt (as ...
4/27/2021, 2:20 PM
by 916
4
Essity is by its nature a ‘boring’ company. But for me its one of the best quality companies in the Nordics (I am a value, long-term investor.) If you have a long-term time horizon and have the patience to wait owning this share it will eventually prove to be successful. The short...
2/4/2021, 1:40 PM
by 916
4
Nostetaanpas Q3 -tulosten johdosta ketjua takaisin ylöspäin. https://masdpstatic.azureedge.net/essity/7039f0d1-f52a-44f4-9327-1a7bb3cbea56/Presentation-Interim-Report-Q3-2020.pdf masdpstatic.azureedge.net Essity_report_eng.pdf 1590.22 KB Liikevaihto putosi vuoden takaisesta, mutta...
10/23/2020, 8:24 AM
by kettunen
3
At least aging population, longer life expectancy, growth in world population and income(Essity is present on emerging markets) as well as increased awareness of the importance of hygiene(emerging markets). How well these trends will translate to revenue growth for Essity is of course...
1/23/2020, 10:42 AM
by purple
2
Read more on our forum
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.